View Post

Tigerlily Foundation Launches a New Web Series, BREATHE Tv on FacebookLive

In In The News by Barbara Jacoby

Tigerlily Foundation in partnership with Puma Biotechnology, Inc. is excited to announce the launch of BREATHE Tv. BREATHE Tv is a sacred space, an educational and inspirational breast cancer lifestyle television series that brings together patients and providers in a space of purpose, while engaging in authentic and meaningful conversations about cancer. The first episode of BREATHE Tv launched on …

View Post

Researchers found that stopping cell recycling in cancer cells could help treat a very aggressive form of breast cancer

In In The News by Barbara Jacoby

Source: University of Cincinnati From: sciencedaily.com Targeting and changing autophagy, otherwise known as cell recycling, has been linked to helping control or diminish certain cancers. Now, researchers have shown that completely halting this process in a very aggressive form of breast cancer may improve outcomes for patients one day. Recycling cans and bottles is a good practice. It helps keep …

View Post

Optiscan Imaging (ASX:OIL) begins stage three of breast cancer study

In Clinical Trials by Barbara Jacoby

By: Julia Seymour From: themarketherald.com Optiscan Imaging (OIL) has begun stage three of its breast cancer study in Melbourne. The study will involve 20 breast cancer patients at Royal Melbourne Hospital, Frances Perry House and Epworth Hospital using Optiscan’s FIVE2/Viewnvivo endomicroscope. The Optiscan endomicroscope enables real-time, 3D, ‘in vivo’ imaging of human tissue at the cellular level, providing instant virtual …

View Post

Laser Therapy May Aid Sexual Function in Breast Cancer Survivors

In In The News by Barbara Jacoby

From: healthday.com Fractional CO2 laser therapy helps improve sexual function among breast cancer survivors with genitourinary syndrome of menopause (GSM), according to a study published online Feb. 1 in Menopause. Allison M. Quick, M.D., from The Ohio State University Medical Center in Columbus, and colleagues evaluated change in sexual function following treatment with fractional CO2 laser therapy in breast cancer …

View Post

Novel hybrid device to boost research on metastatic process of breast cancer cells

In Clinical Trials by Barbara Jacoby

Source: FETFX From: news-medical.net European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells traveling from breast to bone and fast screen new drugs against it. The spread of cancer cells to other parts of the body, known as metastasis, is the main cause of cancer-related deaths. According to the US National …

View Post

Tool predicts chemotherapy-related adverse effects among older adults with breast cancer

In In The News by Barbara Jacoby

By: Jennifer Byrne From: healio.com Age has been identified as a risk factor for complications and toxicities related to various cancer treatments. Additionally, many of these treatments may hasten the aging process in certain patients, according to Mina S. Sedrak, MD, MS, deputy director of clinical trials for the Center for Cancer and Aging Research at City of Hope. “We’re …

View Post

Examining resistance to breast cancer treatments

In Clinical Trials by Barbara Jacoby

By: Molly Chiu From: bcm.edu The combination of CDK4/6 inhibitors with endocrine therapy is the standard of care for patients with estrogen receptor-positive (ER+) and HER2-negative (ER+/HER2-) metastatic breast cancer. However, a subset of patients will have tumors with intrinsic resistance to this therapy and most patients will develop resistant disease at some point during treatment. Researchers at the Lester …

View Post

Removing microRNAs from triple-negative breast cancer cells can reverse its spread

In In The News by Barbara Jacoby

By: University of Westminster From: medicalxpress.com A new study led by the University of Westminster shows that removing small genetic parts of our genomes called microRNAs from triple negative breast cancer cells can reverse its spread. The study, published in the International Journal of Molecular Sciences, also identified that microRNAs could be targeted for early detection and treatment of triple …

View Post

Sanford opens I-SPY 2 clinical trial for breast cancer

In Clinical Trials by Barbara Jacoby

From: sanfordhealth.org Sanford Health has a new option for patients diagnosed with breast cancer. The I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And molecular anaLysis 2), is an adaptive platform clinical trial, created to identify successful treatments for Stage II/III breast cancer while minimizing the number of required participants and time required to …